--- title: "H.C. Wainwright Sticks to Their Buy Rating for LB Pharmaceuticals, Inc. (LBRX)" type: "News" locale: "en" url: "https://longbridge.com/en/news/289088253.md" description: "H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on LB Pharmaceuticals (LBRX) with a $45 price target. The broader analyst consensus for LBRX is Strong Buy, with an average price target of $46.83." datetime: "2026-06-08T17:35:48.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/289088253.md) - [en](https://longbridge.com/en/news/289088253.md) - [zh-HK](https://longbridge.com/zh-HK/news/289088253.md) generator: "portal-rs" --- # H.C. Wainwright Sticks to Their Buy Rating for LB Pharmaceuticals, Inc. (LBRX) In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on LB Pharmaceuticals, Inc., with a price target of $45.00. ### Introducing TipRanks MCP for Agents - Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools. - Designed for personal research, portfolio monitoring, and AI-assisted investment workflows. Selvaraju covers the Healthcare sector, focusing on stocks such as Emergent Biosolutions, Aclaris Therapeutics, and Urogen Pharma. According to TipRanks, Selvaraju has an average return of 18.4% and a 50.10% success rate on recommended stocks. Currently, the analyst consensus on LB Pharmaceuticals, Inc. is a Strong Buy with an average price target of $46.83. ### Related Stocks - [LBRX.US](https://longbridge.com/en/quote/LBRX.US.md) - [EBS.US](https://longbridge.com/en/quote/EBS.US.md) - [ACRS.US](https://longbridge.com/en/quote/ACRS.US.md) - [URGN.US](https://longbridge.com/en/quote/URGN.US.md) ## Related News & Research - [LB Pharma to present at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/297953050.md) - [An NEA partner says not every AI task needs frontier intelligence](https://longbridge.com/en/news/298434703.md) - [Sonos opens platform to connect with outside AI assistants including ChatGPT, Claude via MCP](https://longbridge.com/en/news/298335937.md) - [AI agents keep finding ways to bend the rules. Here are some of the wildest.](https://longbridge.com/en/news/298138114.md) - [Journey Medical CEO Maraoui to present at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/298359762.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**